Correlation Between Crinetics Pharmaceuticals and Savara

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Crinetics Pharmaceuticals and Savara at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Crinetics Pharmaceuticals and Savara into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Crinetics Pharmaceuticals and Savara Inc, you can compare the effects of market volatilities on Crinetics Pharmaceuticals and Savara and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Crinetics Pharmaceuticals with a short position of Savara. Check out your portfolio center. Please also check ongoing floating volatility patterns of Crinetics Pharmaceuticals and Savara.

Diversification Opportunities for Crinetics Pharmaceuticals and Savara

0.89
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Crinetics and Savara is 0.89. Overlapping area represents the amount of risk that can be diversified away by holding Crinetics Pharmaceuticals and Savara Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Savara Inc and Crinetics Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Crinetics Pharmaceuticals are associated (or correlated) with Savara. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Savara Inc has no effect on the direction of Crinetics Pharmaceuticals i.e., Crinetics Pharmaceuticals and Savara go up and down completely randomly.

Pair Corralation between Crinetics Pharmaceuticals and Savara

Given the investment horizon of 90 days Crinetics Pharmaceuticals is expected to under-perform the Savara. In addition to that, Crinetics Pharmaceuticals is 1.37 times more volatile than Savara Inc. It trades about -0.15 of its total potential returns per unit of risk. Savara Inc is currently generating about -0.18 per unit of volatility. If you would invest  272.00  in Savara Inc on November 29, 2024 and sell it today you would lose (25.00) from holding Savara Inc or give up 9.19% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy95.45%
ValuesDaily Returns

Crinetics Pharmaceuticals  vs.  Savara Inc

 Performance 
       Timeline  
Crinetics Pharmaceuticals 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Crinetics Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Savara Inc 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Savara Inc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Crinetics Pharmaceuticals and Savara Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Crinetics Pharmaceuticals and Savara

The main advantage of trading using opposite Crinetics Pharmaceuticals and Savara positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Crinetics Pharmaceuticals position performs unexpectedly, Savara can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Savara will offset losses from the drop in Savara's long position.
The idea behind Crinetics Pharmaceuticals and Savara Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.

Other Complementary Tools

Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas